The Impact of Dutasteride Treatment on Subsequent Multiparametric Prostate Magnetic Resonance Imaging Sequences and PI-RADS Score in Patients With PI-RADS 3 Lesions in the Transitional Zone. [PDF]
Sekkeli S +5 more
europepmc +1 more source
Physicochemical, Predicted ADME, and Structural Positioning of Azelaic Acid Within an Endocrine Oncology Reference Framework. [PDF]
Jurj ED +5 more
europepmc +1 more source
Prescription Trends in the Management of Lower Urinary Tract Symptoms in Men: An Online Survey of Indian Urologists. [PDF]
Patwardhan P +4 more
europepmc +1 more source
Sexual dysfunction associated with 5α-reductase inhibitors in the treatment of androgenetic alopecia: a systematic review. [PDF]
Złotowska A +2 more
europepmc +1 more source
Dutasteride-loaded nanostructured lipid carrier for androgenic alopecia treatment - An <i>in vivo</i> study. [PDF]
Heydari S +6 more
europepmc +1 more source
Drug combination choices of 5α-reductase inhibitors and α-blockers in patients with benign prostatic hyperplasia: a study based on the FAERS database. [PDF]
Qian J, Gong Y, Zhang C, Zhou L.
europepmc +1 more source
5 Alpha Reductase Inhibitors (5ARIs) Monotherapy and Combinations: Current Role in Benign Prostatic Hyperplasia (BPH) Management. [PDF]
Roidos C +4 more
europepmc +1 more source
Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study. [PDF]
Nguyen MH, Ko J, Cho J.
europepmc +1 more source
Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment. [PDF]
Chiappini S +10 more
europepmc +1 more source
Telmisartan Repurposing Targets Novel Biomarkers for Precision Colorectal Cancer Therapy. [PDF]
Hunachagi S +4 more
europepmc +1 more source

